Employers, Payers, and Pharma Face a Post–Labor Day Reckoning
"Tectonic Shifts" are happening as inflation, drug pricing battles, and cash-pay healthcare are colliding to redefine the industry’s next era.
Making sense of healthcare deals, technology, policy, and the occasional industry curveball.
"Tectonic Shifts" are happening as inflation, drug pricing battles, and cash-pay healthcare are colliding to redefine the industry’s next era.
Per our anonymous survey, this is what clinicians take & why
Plus fresh funding rounds and 4 Questions with Commons Clinic’s SVP of Care Services & Strategy.
Reimbursement is patchy, but a big business will be created here as more patients gravitate to messaging
Plus Peloton's surprise profit, 4 Questions with the CSO of Solera Health and a hot-take on AI driven automation.
Why funding has slowed, where gaps remain, and what the next wave of innovation could look like.
Yaccarino's new role, Meta's data fine, Big Pharma going DTC and CVS's 20b bet, big funding rounds, etc
Healthcare companies - and their boards - should get inspired by this tortoise that beat all the hares
That said, I like Amy Gleason’s idea of scanning a QR code at any doctor’s office to pull
AI continues attracting the lions share of investment in healthtech
AI is going to have the biggest impact in areas of healthcare that were previously under-funded
Maybe going direct to employers isn't the fastest path to success